Dr. Zhou leads Color's research and scientific affairs team. She is responsible for leading research collaborations with academic institutions, biopharmaceutical companies, and large population initiatives. She is also responsible for managing a team that initiates, executes, and publishes peer-reviewed manuscripts and posters by Color's scientists and engineers. In addition, Dr. Zhou is an active part of Color's market development team for population genomics and population research. Dr. Zhou received her Ph.D. at Harvard and performed her postdoctoral work at UCSF with an emphasis on cancer genetics.
Polygenic (based on multiple genes/DNA variants) predictions for disease risk and drug response are at the forefront of recent regulatory challenges in precision medicine. Challenges in deployment range from their increased complexity, their clinical actionability, and ethical challenges when a large portion of the input data come from biased subpopulations.